Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
ADA 2026 5 - 8 June 2026

Efficacy and Safety of Semaglutide by Race and Ethnicity in the SELECT Trial 

Authors :

Jamy Ard1; Michael Knight2; Anders Bo Bojesen3; Domenica Rubino4; Signe Stensen3; Andrea Traina5; Lauren Wilson5; Robert F. Kushner6

Affiliations
View Details Hide Details
Download .PDF
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)